Diagnostic agents for positron emission imaging using...

Details Diagnostic agents for positron emission imaging using... Diagnostic agents for positron emission imaging using...

2008-09-23

2008-09-23

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S001810, C424S001850, C424S009400, C424S009100, C424S009450, C424S009451

Reexamination Certificate

active

11049797

ABSTRACT:
New diagnostic agents for positron emission tomography (PET) and methods for use of such agents for imaging of human or animal tissue are described, wherein a primary active component of such agents is a radiolabeled halogenated xanthene or halogenated xanthene derivative. Preferably, the radiolabeled halogenated xanthene is radiolabeled Rose Bengal or a functional derivative of Rose Bengal.

REFERENCES:
patent: 4577636 (1986-03-01), Spears
patent: 5171563 (1992-12-01), Abrams et al.
patent: 5240693 (1993-08-01), Born et al.
patent: 6493570 (2002-12-01), Dees et al.
patent: 846674 (1960-08-01), None
PCT International Search Report and Written Opinion for PCT/US05/16836 dated Nov. 17, 2005.

Affiliated with

Also associated with

Rating

Diagnostic agents for positron emission imaging using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic agents for positron emission imaging using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic agents for positron emission imaging using... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3908838